Media Releases

Media releases

Select a year: 2012 | 2011 | 2010

Dec 21, 2011

Novartis announces termination of ALTITUDE study with aliskiren in high-risk patients with diabetes and renal impairment

Dec 2, 2011

Novartis gains positive CHMP opinion for vildagliptin in EU for patients with type 2 diabetes and moderate or severe renal impairment

Dec 2, 2011

Novartis supports skin health awareness through antifungal cream donation

Dec 2, 2011

Novartis draws attention to aging patients with type 2 diabetes and their growing impact on healthcare resources for World Diabetes Day

Dec 2, 2011

Novartis wins in three major categories of prestigious Scrip Awards

Nov 11, 2011

Novartis diabetes drug vildagliptin provides unique therapeutic benefits, says expert

Oct 12, 2011

Novartis, WHD partners announce ‘Picture of Health’ contest winners

Oct 12, 2011

Novartis Philippines employees participate in first global health and well-being initiative

Sep 21, 2011

Novartis drug vildagliptin shown to be well-tolerated and effective in patients with type 2 diabetes and moderate or severe renal impairment

Sep 8, 2011

New study: Novartis drug significantly reduces hypoglycemic events in South Asian patients with type 2 diabetes fasting for Ramadan

‹ 1-10 11-20 ›

49 Total results

The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.